Cargando…
Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma
Background: Radiation therapy is the mainstay strategy for the treatment of nasopharyngeal cancer (NPC). Intensity-modulated X-ray therapy (IMXT) alone is the current standard for stage I and II NPC. For stage III and IV A/B diseases, concurrent chemotherapy should be provided in addition to IMXT. H...
Autores principales: | Kong, Lin, Hu, Jiyi, Guan, Xiyin, Gao, Jing, Lu, Rong, Lu, Jiade J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860793/ https://www.ncbi.nlm.nih.gov/pubmed/27162535 http://dx.doi.org/10.7150/jca.14399 |
Ejemplares similares
-
Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma
por: Kong, Lin, et al.
Publicado: (2016) -
Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results
por: Hu, Jiyi, et al.
Publicado: (2018) -
Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020) -
Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies
por: Gao, Jing, et al.
Publicado: (2019) -
Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma
por: Hu, Jiyi, et al.
Publicado: (2021)